accountAndrew Witty, CEO of the drug giant GlaxoSmithKline, is making good on his promise to reinvest 20% of the corporation's profits from LDCs back into African healthcare. It's a small pot of gold, but growing. Should...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo to reinvest ��3.5 million of Africa profits in healthcare
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account